[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
Andrew Berens Maintained (ZNTL) at Buy with Decreased Target to $27 on, Nov 10th, 2022
- 🞛 This publication is a summary or evaluation of another publication
Andrew Berens of SVB Leerink, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy with Decreased Target from $42 to $27 on, Nov 10th, 2022.
Andrew has made no other calls on ZNTL in the last 4 months.
There are 4 other peers that have a rating on ZNTL. Out of the 4 peers that are also analyzing ZNTL, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Andrew
- Bradley Canino of "Stifel" Maintained at Strong Buy with Decreased Target to $58 on, Wednesday, November 9th, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $60 on, Thursday, August 11th, 2022
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $55 on, Wednesday, August 10th, 2022
- Tyler Van Buren of "Cowen & Co." Initiated at Buy on, Tuesday, July 12th, 2022